SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-058966
Filing Date
2023-03-03
Accepted
2023-03-03 07:04:04
Documents
16
Period of Report
2023-03-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d422149d8k.htm   iXBRL 8-K 29468
2 EX-1.1 d422149dex11.htm EX-1.1 323604
3 EX-99.1 d422149dex991.htm EX-99.1 18536
7 GRAPHIC g422149dsp60a.jpg GRAPHIC 11568
8 GRAPHIC g422149dsp60b.jpg GRAPHIC 9892
  Complete submission text file 0001193125-23-058966.txt   586494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA teva-20230301.xsd EX-101.SCH 2855
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20230301_lab.xml EX-101.LAB 17166
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20230301_pre.xml EX-101.PRE 10791
10 EXTRACTED XBRL INSTANCE DOCUMENT d422149d8k_htm.xml XML 3309
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 23701618
SIC: 2834 Pharmaceutical Preparations